{"id":"https://openalex.org/W2018746649","doi":"https://doi.org/10.1038/clpt.2009.227","title":"The Biomarkers Consortium: Practice and Pitfalls of Open-Source Precompetitive Collaboration","display_name":"The Biomarkers Consortium: Practice and Pitfalls of Open-Source Precompetitive Collaboration","publication_year":2010,"publication_date":"2010-05-01","ids":{"openalex":"https://openalex.org/W2018746649","doi":"https://doi.org/10.1038/clpt.2009.227","mag":"2018746649","pmid":"https://pubmed.ncbi.nlm.nih.gov/20407460"},"language":"en","primary_location":{"id":"doi:10.1038/clpt.2009.227","doi":"https://doi.org/10.1038/clpt.2009.227","is_oa":false,"landing_page_url":"https://doi.org/10.1038/clpt.2009.227","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111938300","display_name":"John A. Wagner","orcid":"https://orcid.org/0000-0002-0636-5006","observed_orcids":["https://orcid.org/0000-0002-0636-5006","https://orcid.org/0000-0003-0038-8511"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J A Wagner","raw_affiliation_strings":["Merck, Rahway, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck, Rahway, New Jersey, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050701098","display_name":"MELVIN J. PRINCE","orcid":"https://orcid.org/0000-0003-3258-7080","observed_orcids":["https://orcid.org/0000-0003-3258-7080"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M Prince","raw_affiliation_strings":["Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005769736","display_name":"Elizabeth C. Wright","orcid":"https://orcid.org/0000-0002-9841-3879","observed_orcids":["https://orcid.org/0000-0002-9841-3879"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210090567","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210090567"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E C Wright","raw_affiliation_strings":["National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health, Bethesda, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health, Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210090567"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M M Ennis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108991","display_name":"IQVIA (United States)","ror":"https://ror.org/01mk44223","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108991"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M M Ennis","raw_affiliation_strings":["Quintiles, Inc., Austin, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quintiles, Inc., Austin, Texas, USA","institution_ids":["https://openalex.org/I4210108991"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073216300","display_name":"Jarema Peter Kochan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Kochan","raw_affiliation_strings":["Hoffmann\u2013La Roche, Nutley, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoffmann\u2013La Roche, Nutley, New Jersey, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038368144","display_name":"Derek J. Nunez","orcid":"https://orcid.org/0000-0003-4704-3967","observed_orcids":["https://orcid.org/0000-0003-4704-3967"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D J R Nunez","raw_affiliation_strings":["Metabolic Pathways Center of Excellence for Drug Discovery, GlaxoSmithKline, Research Triangle Park, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Metabolic Pathways Center of Excellence for Drug Discovery, GlaxoSmithKline, Research Triangle Park, North Carolina, USA","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015383684","display_name":"B Schneider","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1318287680","display_name":"Center for Biologics Evaluation and Research","ror":"https://ror.org/02nr3fr97","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1318287680","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B Schneider","raw_affiliation_strings":["Center for Biologics Evaluation and Research, US Food and Drug Administration, Rockville, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Biologics Evaluation and Research, US Food and Drug Administration, Rockville, Maryland, USA","institution_ids":["https://openalex.org/I1318287680","https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001981221","display_name":"M-D Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M-D Wang","raw_affiliation_strings":["Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060949113","display_name":"Y Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Y Chen","raw_affiliation_strings":["Merck, Rahway, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck, Rahway, New Jersey, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078766702","display_name":"Sujoy Ghosh","orcid":"https://orcid.org/0000-0002-7601-165X","observed_orcids":["https://orcid.org/0000-0002-7601-165X"]},"institutions":[{"id":"https://openalex.org/I123127086","display_name":"North Carolina Central University","ror":"https://ror.org/051r3tx83","country_code":"US","type":"education","lineage":["https://openalex.org/I123127086"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S Ghosh","raw_affiliation_strings":["Biomedical Biotechnology Research Institute, North Carolina Central University, Durham, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biomedical Biotechnology Research Institute, North Carolina Central University, Durham, North Carolina, USA","institution_ids":["https://openalex.org/I123127086"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056285244","display_name":"Bret J. Musser","orcid":"https://orcid.org/0000-0003-2949-211X","observed_orcids":["https://orcid.org/0000-0003-2949-211X"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B J Musser","raw_affiliation_strings":["Merck, Rahway, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck, Rahway, New Jersey, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102939746","display_name":"Maria T. Vassileva","orcid":"https://orcid.org/0009-0007-1645-8373","observed_orcids":["https://orcid.org/0009-0007-1645-8373"]},"institutions":[{"id":"https://openalex.org/I2800718396","display_name":"Foundation for the National Institutes of Health","ror":"https://ror.org/00k86s890","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2800718396"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M T Vassileva","raw_affiliation_strings":["Foundation for the National Institutes of Health, Bethesda, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation for the National Institutes of Health, Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I2800718396"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":10,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":18.3294,"has_fulltext":false,"cited_by_count":51,"citation_normalized_percentile":{"value":0.98893499,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"87","issue":"5","first_page":"539","last_page":"542"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12766","display_name":"Interdisciplinary Research and Collaboration","score":0.47440001368522644,"subfield":{"id":"https://openalex.org/subfields/1802","display_name":"Information Systems and Management"},"field":{"id":"https://openalex.org/fields/18","display_name":"Decision Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12766","display_name":"Interdisciplinary Research and Collaboration","score":0.47440001368522644,"subfield":{"id":"https://openalex.org/subfields/1802","display_name":"Information Systems and Management"},"field":{"id":"https://openalex.org/fields/18","display_name":"Decision Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.07419999688863754,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14293","display_name":"Biotechnology and Related Fields","score":0.061500001698732376,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/precompetitive-collaboration","display_name":"pre-competitive collaboration","score":0.996999979019165},{"id":"https://openalex.org/keywords/open-source-collaboration","display_name":"open source collaboration","score":0.8479999899864197},{"id":"https://openalex.org/keywords/biomarker-qualification","display_name":"biomarker qualification","score":0.824999988079071},{"id":"https://openalex.org/keywords/adiponectin","display_name":"adiponectin","score":0.9909999966621399},{"id":"https://openalex.org/keywords/ppar-agonists","display_name":"PPAR agonists","score":0.8899999856948853},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9779999852180481},{"id":"https://openalex.org/keywords/public-private-partnerships","display_name":"public-private partnerships","score":0.847000002861023},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.7670000195503235}],"concepts":[{"id":"https://openalex.org/C63433958","wikidata":"https://www.wikidata.org/wiki/Q1774688","display_name":"Clinical pharmacology","level":2,"score":0.5740657448768616},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4810333847999573},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.48026204109191895},{"id":"https://openalex.org/C2910266098","wikidata":"https://www.wikidata.org/wiki/Q419629","display_name":"Peroxisome proliferator","level":4,"score":0.4588734209537506},{"id":"https://openalex.org/C2776782570","wikidata":"https://www.wikidata.org/wiki/Q357439","display_name":"Adiponectin","level":4,"score":0.42501014471054077},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.4137348234653473},{"id":"https://openalex.org/C32220436","wikidata":"https://www.wikidata.org/wiki/Q2072214","display_name":"Personalized medicine","level":2,"score":0.4124823212623596},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2650858461856842},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25965896248817444},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.2367887794971466},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.23622053861618042},{"id":"https://openalex.org/C187345961","wikidata":"https://www.wikidata.org/wiki/Q419629","display_name":"Peroxisome proliferator-activated receptor","level":3,"score":0.18230563402175903},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.17022481560707092},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12272068858146667},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.0932140052318573},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07115384936332703},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003299","descriptor_name":"Cooperative Behavior","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004345","descriptor_name":"Drug Industry","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D004345","descriptor_name":"Drug Industry","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D004345","descriptor_name":"Drug Industry","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":false},{"descriptor_ui":"D004465","descriptor_name":"Economic Competition","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D004465","descriptor_name":"Economic Competition","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1038/clpt.2009.227","doi":"https://doi.org/10.1038/clpt.2009.227","is_oa":false,"landing_page_url":"https://doi.org/10.1038/clpt.2009.227","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},{"id":"pmid:20407460","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20407460","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W1523514583","https://openalex.org/W2023025887","https://openalex.org/W2024672522","https://openalex.org/W2044865802","https://openalex.org/W2046475112","https://openalex.org/W2048784330","https://openalex.org/W2051111981","https://openalex.org/W2072941580","https://openalex.org/W2139694010"],"related_works":["https://openalex.org/W2072758030","https://openalex.org/W2274280457","https://openalex.org/W2770071582","https://openalex.org/W1967723826","https://openalex.org/W2094523641","https://openalex.org/W2302988544","https://openalex.org/W4387298441","https://openalex.org/W2497875324","https://openalex.org/W2534385055","https://openalex.org/W2005766769"],"abstract_inverted_index":{"Precompetitive":[0],"collaboration":[1,25,69],"is":[2,65,70],"a":[3,20,36,71],"growing":[4],"driver":[5],"for":[6,23],"innovation":[7],"and":[8,14],"increased":[9],"productivity":[10],"in":[11,47],"biomedical":[12],"science":[13],"drug":[15],"development.":[16],"The":[17],"Biomarkers":[18],"Consortium,":[19],"public-private":[21],"platform":[22],"precompetitive":[24,68],"specific":[26],"to":[27,41,75],"biomarkers,":[28],"demonstrated":[29],"that":[30,66],"adiponectin":[31],"has":[32],"potential":[33],"utility":[34],"as":[35],"predictor":[37],"of":[38],"metabolic":[39],"responses":[40],"peroxisome":[42],"proliferator-activated":[43],"receptor":[44],"(PPAR)":[45],"agonists":[46],"individuals":[48],"with":[49],"type":[50],"2":[51],"diabetes.":[52],"Despite":[53],"the":[54,60],"challenges":[55],"overcome":[56],"by":[57],"this":[58],"project,":[59],"most":[61],"important":[62],"lesson":[63],"learned":[64],"cross-company":[67],"feasible":[72],"robust":[73],"approach":[74],"biomarker":[76],"qualification.":[77]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":8}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}